BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

4:47 PM
 | 
Feb 20, 2008
 |  BC Extra  |  Company News

Vernalis up on restructuring plans, settlement

Vernalis (LSE:VER) gained 1.03p (14%) to 8.35p on Wednesday after announcing plans to restructure and settle a $56 million loan with Endo (NASDAQ:ENDP). Vernalis said it made the moves due to a September FDA not approvable letter for an sNDA for Frova frovatriptan tablets for the short-term prevention of menstrual migraine. Approval of the sNDA would have triggered a $40 million milestone payment to...

Read the full 319 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >